Legend Biotech Corp Quarterly Liabilities in USD from Q4 2019 to Q4 2023

Taxonomy & unit: ifrs-full: USD
Summary: Legend Biotech Corp quarterly Liabilities history and growth rate from Q4 2019 to Q4 2023.
Legend Biotech Corp Liabilities for the quarter ending December 31, 2023 was $597M, a 1.81% increase year-over-year.

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$597M	+$10.6M	+1.81%	Dec 31, 2023	20-F	2024-03-19
Q3 2023	$500M			Sep 30, 2023	6-K	2023-11-20
Q2 2023	$524M			Jun 30, 2023	6-K	2023-08-15
Q4 2022	$587M	+$233M	+65.9%	Dec 31, 2022	20-F	2024-03-19
Q4 2021	$354M	+$229M	+184%	Dec 31, 2021	20-F	2023-03-30
Q2 2021	$535M			Jun 30, 2021	6-K	2021-08-23
Q4 2020	$124M	-$286M	-69.7%	Dec 31, 2020	20-F/A	2023-02-17
Q4 2019	$411M			Dec 31, 2019	20-F	2021-04-02

* An asterisk sign (*) next to the value indicates that the value is likely invalid.